Quantification of EGFR family in canine mammary ductal carcinomas in situ: implications on the histological graduation
The epithelial growth factor receptors are transmembrane proteins with an important role in the neoplastic progression of tumors, and in this context, DCIS is an important phase in the progression of canine mammary tumors. Studies on the molecular profile and its relationship to a progression of canine mammary tumors are important to improve the treatment of patients and for a better understanding of canine mammary carcinogenesis. The aim of this study was to determine, by immunohistochemistry, the relation between the expression of EGFR, ErbB-2, ErbB-3, and ErbB-4 in 52 canine mammary gland DCIS with high and low histological grade. A positive correlation between histological grade and expression of membrane ErbB-2 and cytoplasmic ErbB-4 was observed. Increased ErbB-4 membrane expression was correlated with increased ErbB-3 expression in low and high-grade DCIS. Our data suggest that increased expression of ErbB-2 and ErbB-4 may be related to more aggressive DCIS and probabily involved with canine mammary neoplastic progression.
KeywordsCancer Dog Immunohistochemistry Histological grade EGFR
The financial support for this study was provided by Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.
Compliance with ethical standards
Conflict of interest
The authors have no competing interests.
- Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R (2010) National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst 102:161–169CrossRefGoogle Scholar
- Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P (2014) Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. Breast 23:637–643. https://doi.org/10.1016/j.breast.2014.06.011 CrossRefGoogle Scholar
- Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire W (1990) HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 50:4332–4337Google Scholar
- Cassali GD, Lavalle GE, Ferreira E et al (2014) Consensus for the diagnosis, prognosis and treatment of canine mammary tumors - 2013. Brazilian J Vet Pathol 7:38–69Google Scholar
- Ellis IO, Schnitt SJ, Bussalati G, Tavassoli FA (2003) CHAPTER 1 WHO histological classification of Tumours of the breast. Pathol Genet Breast Female Genit OrgansGoogle Scholar
- Han S, Yun I-J, Noh D-Y, Choe KJ, Song SY, Chi JG (1997) Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbb-2, and cathepsin D protein. J Surg Oncol 65:22–27. https://doi.org/10.1002/(SICI)1096-9098(199705)65:1<22::AID-JSO5>3.0.CO;2-Q CrossRefGoogle Scholar
- Koutras AK, Kalogeras KT, Dimopoulos M-A et al (2008) Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic cooperative oncology group (HeCOG) study. Br J Cancer 99:1775–1785. https://doi.org/10.1038/sj.Bjc.6604769 CrossRefGoogle Scholar
- Le Doussal V, Tubiana-Hulin M, Friedman S et al (1989) Prognostic value of histologic grade nuclear components of Scarff - bloom - Richardson (SBR) an improved score modification based on a multivariate analysis of 1262 lnvasive ductal breast carcinomas. Cancer 64:1914–1921. https://doi.org/10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G CrossRefGoogle Scholar
- Misdorp W, Else RW, Hellmén E, Lipscomb TP (1999) Histological classification of mammary tumors of the dog and the cat 2nd series, vol VII, WashingtonGoogle Scholar
- Queiroga FL, Perez-Alenza MD, González-Gil A, Silván G, Peña L, Illera JC (2017) Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications. Vet Comp Oncol 15:383–390. https://doi.org/10.1111/vco.12174 CrossRefGoogle Scholar
- Rampaul RS, Pinder SE, Wencyk PM et al (2004) Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value? Clin Cancer Res 10:2578Google Scholar
- Rao NAS, Van Wolferen ME, Gracanin A et al (2009) Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. J Physiol Pharmacol 60:73–84Google Scholar
- Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B, Earp HS (2001) HER4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 21:4265–4275. https://doi.org/10.1128/MCB.21.13.4265 CrossRefGoogle Scholar
- Sgroi DC (2010) Preinvasive breast cancer. Annu Rev Pathol 5:193–221. https://doi.org/10.1146/annurev.pathol.4.110807.092306 CrossRefGoogle Scholar
- Siegel PM, Ryan ED, Cardiff RD, Muller WJ (1999) Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 18:2149–2164. https://doi.org/10.1093/emboj/18.8.2149 CrossRefGoogle Scholar
- Steinman S, Wang J, Bourne P et al (2007) Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci 37:127–134Google Scholar
- Tang Q, Liu Y, Li T et al (2016) A novel co-drug of aspirin and ursolic acid interrupts adhesion, invasion and migration of cancer cells to vascular endothelium via regulating EMT and EGFR-mediated signaling pathways: multiple targets for cancer metastasis prevention and treatment. Oncotarget. https://doi.org/10.18632/oncotarget.12232